There have been few reports of nifekalant （NIF） for the management of arrhythmias in children, and its efficacy and safety remains to be established. We studied children treated with NIF in our institution. Methods: The subjects were 28 patients （6 days to 18 years old; 20 males and 8 females） who received NIF. NIF was used to manage postoperative arrhythmias in 25 patients with congenital heart disease and in 3 patients with cardiomyopathy. We retrospectively studied the antiarrhythmic effectiveness and characteristics of patients with torsades de pointes （Tdp） . 
Fig．2 Receiver-operating-characteristic curves of heart rate, QTc （B） , and QTc （F） for prediction of torsades de pointes. 
